TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Yomeishu Seizo Co., Ltd. ( (JP:2540) ) is now available.
Yomeishu Seizo Co., Ltd. reported its non-consolidated financial results for the fiscal year ended March 31, 2025, showing a decline in net sales and profits compared to the previous year. Despite the decrease, the company maintains a strong capital adequacy ratio and plans to continue its dividend payments, indicating a stable financial position. The forecast for the next fiscal year suggests a positive outlook with expected growth in net sales and profits, which could enhance its market position and benefit stakeholders.
More about Yomeishu Seizo Co., Ltd.
Yomeishu Seizo Co., Ltd. operates in the pharmaceutical industry, primarily focusing on the production and sale of herbal medicines and health-related products. The company is listed on the Tokyo Stock Exchange and is known for its traditional Japanese herbal liqueur, Yomeishu.
Average Trading Volume: 29,731
Technical Sentiment Signal: Buy
Current Market Cap: Yen41.44B
See more data about 2540 stock on TipRanks’ Stock Analysis page.